MUFG Securities EMEA’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
MUFG Securities EMEA's MRNA Position: Q2 2026 in Review
MUFG Securities EMEA reduced its Moderna (MRNA) stake by 2.7% in Q2 2026, selling an estimated $20.2K and leaving 13,822 shares worth $968K. The position accounts for 0.01% of the portfolio, ranked #426.
MUFG Securities EMEA first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- MUFG Securities EMEA held 13,822 shares of Moderna worth $968K as of Q2 2026.
- MUFG Securities EMEA sold 390 Moderna shares in Q2 2026, an estimated $20.2K.
- Moderna made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #426 holding.
- MUFG Securities EMEA first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
- 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.